ULK TPD
Alternative Names: ULK-TPDLatest Information Update: 15 Jul 2024
At a glance
- Originator Txinno Bioscience
- Class Antineoplastics
- Mechanism of Action Autophagy-related protein-1 homolog inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 27 Jun 2024 Early research in Cancer in South Korea (unspecified route) (Txinno Bioscience pipeline; June 2024)